Publications

Abstract not provided.

Viruses within a given family often share common essential genes that are highly conserved due to their critical role for the virus’s replication and survival. In this work, we developed a proof-of-concept for a pan-coronavirus CRISPR effector system by designing CRISPR targets that are cross-reactive among essential genes of different human coronaviruses (HCoV). We designed CRISPR targets for both the RNA-dependent RNA polymerase (RdRp) gene as well as the nucleocapsid (N) gene in coronaviruses. Using sequencing alignment, we determined the most highly conserved regions of these genes to design guide RNA (gRNA) sequences. In regions that were not completely homologous among HCoV species, we introduced mismatches into the gRNA sequence and tested the efficacy of CasRx, a Cas13d type CRISPR effector, using reverse transcription quantitative polymerase chain reaction (RT-qPCR) in HCoV-OC43. We evaluated the effect that mismatches in gRNA sequences has on the cleavage activity of CasRx and found that this CRISPR effector can tolerate up to three mismatches while still maintaining its nuclease activity in HCoV-OC43 viral RNA. This work highlights the need to evaluate off-target effects of CasRx with gRNAs containing up to three mismatches in order to design safe and effective CRISPR experiments.

The AG-4000 detector can identify gas phase species using molecular fingerprinting and has potential application for SARS-CoV-2 detection in near real time. As part of the development process Sandia will utilize the biological aerosol test bed deployed at the Aerosol Complex to evaluate the penetration of MS2 bacteriophage aerosol through the Ring IR system. The objective of this project is to provide experimentally derived measurements of the RingIR AG-4000 penetration efficiency, including external exhaust filter for mitigation of exhaust aerosol and operation using MS2 bacteriophage as a biological surrogate to the SARS-CoV-2 virus.

The Universal Citizen Protection Device (UCPD) is a UV-based, filterless PPE concept developed by Helpful Engineering that aims to keep viral particles out of eyes, nose and mouth with a 99%+ reliability. The heart of the device is a concealed UV chamber that decontaminates all air going in and out of the PPE. The objective of this project was to provide measurements as evidence of proof of function of a representative prototype. Sandia utilized its aerosol characterization facility to measure the amount of virus that is inactivated by the device at representative flow rates and concentrations, using MS2 bacteriophage as the BSL-1 viral surrogate.

Abstract not provided.

Here, we describe a new method to measure the activation energy required to remove a strongly-bound membrane-associated protein from a lipid membrane (anchoring energy). It is based on measuring the rate of release of a liposome-bound protein during centrifugation on a sucrose gradient as a function of time and temperature. The method was used to determine anchoring energy for the soluble dengue virus envelope protein (sE) strongly bound to 80:20 POPC:POPG liposomes at pH 5.5. We also measured the binding energy of sE at the same pH for the initial, predominantly reversible, phase of binding to a 70:30 PC:PG lipid bilayer. The anchoring energy (37 +/- 1.7 kcal/mol, 20% PG) was found to be much larger than the binding energy (7.8 +/- 0.3 kcal/mol for 30% PG, or est. 7.0 kcal/mol for 20% PG). This is consistent with data showing that free sE is a monomer at pH 5.5, but assembles into trimers after associating with membranes. But, trimerization alone is insufficient to account for the observed difference in energies, and we conclude that some energy dissipation occurs during the release process. This new method to determine anchoring energy should be useful to understand the complex interactions of integral monotopic proteins and strongly-bound peripheral membrane proteins with lipid membranes.